How India's Drug Exports May Have a Safety Problem
In 2019, doctors at hospitals in Colombia began reporting that patients treated with a commonly used cancer drug were developing high fevers, “altered states of consciousness” and other concerning symptoms.
They suspected that more than 100 patients had suffered reactions linked to the contaminated medicine. Four children died, including a six-year-old girl named Valery.
The drug they were given was made by Naprod Life Sciences in India, a crucial but sometimes unnoticed maker of low-cost generic cancer medicine. None of the medicine the company makes is approved for sale in the US, where regulations are tougher. Naprod can sell some medicine in Europe but said it currently is not.
This is the story of how a drugmaker with a record of safety lapses and quality concerns keeps selling medicine, leaving patients and families to suffer the consequences.
Read the full story: http://www.trib.al/NPh1C4F
Get unlimited access to Bloomberg.com for $1.99/month for the first 3 months: https://www.bloomberg.com/subscriptions?in_source=YoutubeOriginals
--------
Like this video? Subscribe: http://www.youtube.com/Bloomberg?sub_confirmation=1
Become a Quicktake Member for exclusive perks: http://www.youtube.com/bloomberg/join
Bloomberg Originals offers bold takes for curious minds on today’s biggest topics. Hosted by experts covering stories you haven’t seen and viewpoints you haven’t heard, you’ll discover cinematic, data-led shows that investigate the intersection of business and culture. Exploring every angle of climate change, technology, finance, sports and beyond, Bloomberg Originals is business as you’ve never seen it.
Subscribe for business news, but not as you've known it: exclusive interviews, fascinating profiles, data-driven analysis, and the latest in tech innovation from around the world.
Visit our partner channel Bloomberg Quicktake for global news and insight in an instant.
Видео How India's Drug Exports May Have a Safety Problem канала Bloomberg Originals
They suspected that more than 100 patients had suffered reactions linked to the contaminated medicine. Four children died, including a six-year-old girl named Valery.
The drug they were given was made by Naprod Life Sciences in India, a crucial but sometimes unnoticed maker of low-cost generic cancer medicine. None of the medicine the company makes is approved for sale in the US, where regulations are tougher. Naprod can sell some medicine in Europe but said it currently is not.
This is the story of how a drugmaker with a record of safety lapses and quality concerns keeps selling medicine, leaving patients and families to suffer the consequences.
Read the full story: http://www.trib.al/NPh1C4F
Get unlimited access to Bloomberg.com for $1.99/month for the first 3 months: https://www.bloomberg.com/subscriptions?in_source=YoutubeOriginals
--------
Like this video? Subscribe: http://www.youtube.com/Bloomberg?sub_confirmation=1
Become a Quicktake Member for exclusive perks: http://www.youtube.com/bloomberg/join
Bloomberg Originals offers bold takes for curious minds on today’s biggest topics. Hosted by experts covering stories you haven’t seen and viewpoints you haven’t heard, you’ll discover cinematic, data-led shows that investigate the intersection of business and culture. Exploring every angle of climate change, technology, finance, sports and beyond, Bloomberg Originals is business as you’ve never seen it.
Subscribe for business news, but not as you've known it: exclusive interviews, fascinating profiles, data-driven analysis, and the latest in tech innovation from around the world.
Visit our partner channel Bloomberg Quicktake for global news and insight in an instant.
Видео How India's Drug Exports May Have a Safety Problem канала Bloomberg Originals
Показать
Комментарии отсутствуют
Информация о видео
Другие видео канала
![Will We See More Kraft, Heinz Like Mergers?](https://i.ytimg.com/vi/JEXQfSWMozg/default.jpg)
![Why Fashion Brands Are Doubling Down on Sustainability | The Business of Fashion Show](https://i.ytimg.com/vi/iMyUgoL1mI8/default.jpg)
![How TeamLab Builds Incredible Techno Art Exhibits](https://i.ytimg.com/vi/_pZr4TrmenE/default.jpg)
![The Evocative Fabric Stylings of Do Ho Suh | Brilliant Ideas Ep. 38](https://i.ytimg.com/vi/jbL4jsC0itw/default.jpg)
![The Technology That Could Make Blind People See Again](https://i.ytimg.com/vi/SJUWPD62MTI/default.jpg)
![How South Korea Built a City Out of The Sea](https://i.ytimg.com/vi/vrIl3VRGl-w/default.jpg)
![Kanye West: You Have to Take the Lashes of Backlash](https://i.ytimg.com/vi/mRIBq-k_YA0/default.jpg)
![How Japan Is Building Disaster-Proof Skyscrapers](https://i.ytimg.com/vi/c5X8OK1V2_c/default.jpg)
![This Accidental Treatment Is Reversing Paralysis](https://i.ytimg.com/vi/KCpYa8DsUhA/default.jpg)
![My First Line of Code: Linus Torvalds](https://i.ytimg.com/vi/S5S9LIT-hdc/default.jpg)
![How Fashion Megabrands Will Adapt to Post-Pandemic Life | The Business of Fashion Show](https://i.ytimg.com/vi/ZK-zhYptqaU/default.jpg)
![The Music Plays On…Demand | System Shock Ep 3](https://i.ytimg.com/vi/392B71DgBCY/default.jpg)
![How Covid Is Transforming the $380 Billion Luxury Fashion Industry | The Business of Fashion Show](https://i.ytimg.com/vi/SoNu7gNl1I4/default.jpg)
![The Innovators Using Nature's Design Principles to Create Green Tech](https://i.ytimg.com/vi/6WjBvFwQpYU/default.jpg)
![Reversing The World's Fastest Spreading Disease](https://i.ytimg.com/vi/4jaqnQ_GMWU/default.jpg)
![U-Ram Choe, Self-Taught Robotics Whiz | Brilliant Ideas Ep. 27](https://i.ytimg.com/vi/dYdOuFEvHzM/default.jpg)
![These Devices Let You Hear Through Your Skin](https://i.ytimg.com/vi/285Jg0WN2yo/default.jpg)
![Cambridge is More Than a University Town](https://i.ytimg.com/vi/-y_NmpxZPjM/default.jpg)
![How Slicing Up Brains Could Unlock the Mind's Secrets](https://i.ytimg.com/vi/OAWISbU9Mv8/default.jpg)
![Credit Suisse’s Final Days: The Race to Avert a New Banking Crisis](https://i.ytimg.com/vi/J2YiOfxNkIQ/default.jpg)
![Why Investors Are Piling into African Startups](https://i.ytimg.com/vi/4aZDNO7c8Z8/default.jpg)